SCHEMBL6682834

SCHEMBL6682834

CCCOc1c(Br)cc(C(C)C)cc1C(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 9/20 0.44
PPARG P37231 5/20 0.44
RARG P13631 4/20 0.44
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
RARB P10826 2/20 0.40
RARA P10276 3/20 0.39
RXRB P28702 2/20 0.39
RXRG P48443 2/20 0.39
ALDH1A1 P00352 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
HPGD P15428 1/20 0.38
HTT P42858 1/20 0.38
MAPT P10636 1/20 0.36
RAB9A P51151 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
THRA P10827 4/20 0.36
THRB P10828 4/20 0.36
GABRA1 P14867 1/20 0.34
GABRB2 P47870 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4850986 0.88 RXRA (0.41) RXRAPPARGRARGKMT2ARARA
SCHEMBL4852964 0.78 RXRA (0.46) RXRAPPARGRARGRARBRARA
SCHEMBL6692114 0.78 LMNA (0.43) RXRAPPARGRARGMEN1KMT2A
SCHEMBL8780259 0.75 GLRA1 (0.53) MEN1KMT2AALDH1A1SMN1; SMN2HPGD
SCHEMBL9191371 0.74 RXRA (0.60) RXRAPPARGRARGRARBRARA
SCHEMBL10212529 0.74 RXRA (0.46) RXRAPPARGRARGRARBRARA
SCHEMBL14416510 0.74 THRB (0.43) MEN1KMT2ASMN1; SMN2RAB9ATHRA
SCHEMBL6687586 0.73 RXRA (0.53) RXRAPPARGRARGRARBRARA
Zinc Ion SCHEMBL9191366 0.73 RXRA (0.56) RXRAPPARGRARGRARBRARA
SCHEMBL7067871 0.72 MEN1 (0.40) MEN1KMT2AALDH1A1SMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004069781-A2 7-(3,5-DIISOPROPYLPHENYL) HEPTATRIENOIC ACID DERIVATIVES HAVING SERUM GLUCOSE REDUCING ACTIVITY ALLERGAN, INC. (US) 2004-08-19 WO disclosed
US-6759546-B1 REDUCING SERUM GLUCOSE AND SERUM TRIGLYCERIDE LEVELS IN DIABETIC MAMMALS WITHOUT THE UNDESIRABLE PROPERTY OF REDUCING SERUM THYROXINE LEVELS ALLERGAN, INC. 2004-07-06 US disclosed